GSTM1 and lung carcinoma: The most frequently studied phase I and II enzymes include CYP1A1 and GSTM1. Studies from Japanese populations first found an association between CYP1A1 and polymorphisms and risk of lung cancer, with reports of >2-fold increased risk [18].